Scion Life Sciences

Scion Life Sciences is a New York City-based life sciences venture capital firm dedicated to founding and building exceptional biotechnology companies that discover, develop, and seek to commercialize clinically transformational or curative new medicines. The company is committed to meaningfully improving human health through long-term ownership of clinically transformative therapies and aims to support impactful and sustainable advancements with a strategic and pragmatic approach to investment and innovation.

Scion's mission is to create medicines that cure or transform the clinical management of serious and life-threatening diseases, and this objective informs every aspect of the firm's strategy and approach. The company is structured to support its most promising portfolio companies through to maturity as late- or commercial-stage biopharmaceutical enterprises, providing the long-term capital and operational resources required to realize the mature clinical potential of the therapies they discover and develop.